annual CFO:
-$389.84M-$93.78M(-31.68%)Summary
- As of today (June 1, 2025), AGIO annual cash flow from operations is -$389.84 million, with the most recent change of -$93.78 million (-31.68%) on December 31, 2024.
- During the last 3 years, AGIO annual CFO has risen by +$17.48 million (+4.29%).
- AGIO annual CFO is now -1110.95% below its all-time high of $38.56 million, reached on December 31, 2016.
Performance
AGIO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$111.49M+$21.68M(+16.28%)Summary
- As of today (June 1, 2025), AGIO quarterly cash flow from operations is -$111.49 million, with the most recent change of +$21.68 million (+16.28%) on March 31, 2025.
- Over the past year, AGIO quarterly CFO has dropped by -$11.62 million (-11.64%).
- AGIO quarterly CFO is now -170.64% below its all-time high of $157.82 million, reached on June 30, 2016.
Performance
AGIO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$401.46M-$11.62M(-2.98%)Summary
- As of today (June 1, 2025), AGIO TTM cash flow from operations is -$401.46 million, with the most recent change of -$11.62 million (-2.98%) on March 31, 2025.
- Over the past year, AGIO TTM CFO has dropped by -$100.72 million (-33.49%).
- AGIO TTM CFO is now -580.96% below its all-time high of $83.47 million, reached on June 30, 2016.
Performance
AGIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AGIO Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.7% | -11.6% | -33.5% |
| 3 y3 years | +4.3% | -14.1% | -4.5% |
| 5 y5 years | -5.2% | -5.8% | -7.7% |
AGIO Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | +4.3% | -80.9% | +16.3% | -38.6% | at low |
| 5 y | 5-year | -34.1% | +4.3% | -125.7% | +16.3% | -38.6% | +1.4% |
| alltime | all time | -1111.0% | +4.3% | -170.6% | +16.3% | -581.0% | +1.4% |
AGIO Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$111.49M(-16.3%) | -$401.46M(+3.0%) |
| Dec 2024 | -$389.84M(+31.7%) | -$133.17M(+58.1%) | -$389.84M(+18.4%) |
| Sep 2024 | - | -$84.22M(+16.0%) | -$329.16M(+7.4%) |
| Jun 2024 | - | -$72.59M(-27.3%) | -$306.59M(+1.9%) |
| Mar 2024 | - | -$99.87M(+37.8%) | -$300.75M(+1.6%) |
| Dec 2023 | -$296.06M(-4.3%) | -$72.49M(+17.6%) | -$296.06M(+2.2%) |
| Sep 2023 | - | -$61.64M(-7.6%) | -$289.74M(-3.2%) |
| Jun 2023 | - | -$66.75M(-29.9%) | -$299.44M(-2.4%) |
| Mar 2023 | - | -$95.18M(+43.9%) | -$306.93M(-0.8%) |
| Dec 2022 | -$309.48M(-24.0%) | -$66.16M(-7.3%) | -$309.48M(-5.5%) |
| Sep 2022 | - | -$71.35M(-3.9%) | -$327.41M(-4.1%) |
| Jun 2022 | - | -$74.23M(-24.1%) | -$341.24M(-11.2%) |
| Mar 2022 | - | -$97.73M(+16.2%) | -$384.31M(-5.7%) |
| Dec 2021 | -$407.32M(+40.1%) | -$84.09M(-1.3%) | -$407.32M(+9.3%) |
| Sep 2021 | - | -$85.18M(-27.4%) | -$372.62M(+4.8%) |
| Jun 2021 | - | -$117.29M(-2.9%) | -$355.65M(+16.2%) |
| Mar 2021 | - | -$120.75M(+144.4%) | -$306.15M(+5.3%) |
| Dec 2020 | -$290.76M(-21.5%) | -$49.40M(-27.6%) | -$290.76M(-13.2%) |
| Sep 2020 | - | -$68.21M(+0.6%) | -$334.97M(-4.9%) |
| Jun 2020 | - | -$67.80M(-35.7%) | -$352.36M(-5.5%) |
| Mar 2020 | - | -$105.36M(+12.5%) | -$372.71M(+0.6%) |
| Dec 2019 | -$370.62M(+21.7%) | -$93.61M(+9.4%) | -$370.62M(+5.5%) |
| Sep 2019 | - | -$85.59M(-2.9%) | -$351.20M(+6.6%) |
| Jun 2019 | - | -$88.15M(-14.6%) | -$329.45M(+6.7%) |
| Mar 2019 | - | -$103.27M(+39.2%) | -$308.69M(+1.4%) |
| Dec 2018 | -$304.42M | -$74.19M(+16.2%) | -$304.42M(-0.1%) |
| Sep 2018 | - | -$63.84M(-5.3%) | -$304.69M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$67.39M(-31.9%) | -$318.56M(+2.7%) |
| Mar 2018 | - | -$99.00M(+33.0%) | -$310.16M(+8.7%) |
| Dec 2017 | -$285.23M(-839.7%) | -$74.45M(-4.2%) | -$285.23M(+8.9%) |
| Sep 2017 | - | -$77.72M(+31.7%) | -$262.00M(+12.3%) |
| Jun 2017 | - | -$58.99M(-20.4%) | -$233.32M(+1313.8%) |
| Mar 2017 | - | -$74.07M(+44.6%) | -$16.50M(-142.8%) |
| Dec 2016 | $38.56M(-150.1%) | -$51.22M(+4.5%) | $38.56M(-34.9%) |
| Sep 2016 | - | -$49.03M(-131.1%) | $59.26M(-29.0%) |
| Jun 2016 | - | $157.82M(-930.3%) | $83.47M(-218.6%) |
| Mar 2016 | - | -$19.01M(-37.7%) | -$70.37M(-8.5%) |
| Dec 2015 | -$76.95M(+29.6%) | -$30.53M(+23.0%) | -$76.95M(+42.0%) |
| Sep 2015 | - | -$24.82M(-723.5%) | -$54.20M(+2.6%) |
| Jun 2015 | - | $3.98M(-115.6%) | -$52.85M(-8.7%) |
| Mar 2015 | - | -$25.59M(+229.1%) | -$57.90M(-2.5%) |
| Dec 2014 | -$59.35M(+5.2%) | -$7.78M(-66.9%) | -$59.35M(-9.0%) |
| Sep 2014 | - | -$23.47M(+2091.1%) | -$65.19M(+15.0%) |
| Jun 2014 | - | -$1.07M(-96.0%) | -$56.71M(-20.6%) |
| Mar 2014 | - | -$27.04M(+98.6%) | -$71.46M(+26.7%) |
| Dec 2013 | -$56.40M(+13.8%) | -$13.62M(-9.1%) | -$56.40M(+3.7%) |
| Sep 2013 | - | -$14.98M(-5.3%) | -$54.41M(+7.0%) |
| Jun 2013 | - | -$15.82M(+32.1%) | -$50.83M(+11.6%) |
| Mar 2013 | - | -$11.98M(+3.0%) | -$45.55M(-8.1%) |
| Dec 2012 | -$49.55M(+225.6%) | -$11.63M(+2.0%) | -$49.55M(+30.7%) |
| Sep 2012 | - | -$11.40M(+8.1%) | -$37.92M(+43.0%) |
| Jun 2012 | - | -$10.55M(-34.0%) | -$26.52M(+66.0%) |
| Mar 2012 | - | -$15.97M | -$15.97M |
| Dec 2011 | -$15.22M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CFO year-on-year change?
- What is Agios Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFO year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFO year-on-year change?
What is Agios Pharmaceuticals annual cash flow from operations?
The current annual CFO of AGIO is -$389.84M
What is the all time high annual CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from operations is $38.56M
What is Agios Pharmaceuticals annual CFO year-on-year change?
Over the past year, AGIO annual cash flow from operations has changed by -$93.78M (-31.68%)
What is Agios Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AGIO is -$111.49M
What is the all time high quarterly CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from operations is $157.82M
What is Agios Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AGIO quarterly cash flow from operations has changed by -$11.62M (-11.64%)
What is Agios Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AGIO is -$401.46M
What is the all time high TTM CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from operations is $83.47M
What is Agios Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AGIO TTM cash flow from operations has changed by -$100.72M (-33.49%)